ReviewJournal of inflammation research2025

Dual Targeting of Inflammatory and Immune Checkpoint Pathways to Overcome Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

Zhifeng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.